News
Hosted on MSN21d
Axsome's ADHD drug meets main goal in late-stage study(Reuters) -Axsome Therapeutics said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met its main goal of improving symptoms in a late-stage study.
(Reuters) -Axsome Therapeutics said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met its main goal in a late-stage study. The drug, solriamfetol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback